技術外包服務:

★-α抗體說明書 分子生物學：質粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構建等

★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構建、細胞RNAi技術等等。

實驗流程：

-α抗體說明書 英文名稱  Anti-TNF-alpha

中文名稱  -α抗體說明書 

別    名 APC1; Cachectin; DIF; Differentiation inducing factor; Macrophage cytotoxic factor; MCF; Necrosin; TNF a; TNF alpha; TNF; TNF Macrophage Derived; TNF Monocyte Derived; TNF Superfamily Member 2; TNFA; TNFSF2; Tumor necrosis factor ligand superfamily member 2; Tumor Necrosis Factor Precursor; Tumour Necrosis Factor Alpha; TNFA_HUMAN.

產品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應   Human, Dog, Pig, Rabbit

產品類型   一抗  

研究領域     細胞生物 信號轉導 細胞凋亡 生長因子和激素 轉錄調節(jié)因子

蛋白分子量  predicted molecular weight: 17/26kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human TNF-alpha

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

-α抗體說明書 產品應用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產品介紹 Tumor Necrosis Factor Alpha (TNF alpha) is a protein secreted by lipopolysaccharide stimulated macrophages, and causes tumor necrosis when injected into tumour bearing mice. TNF alpha is believed to mediate pathogenic shock and tissue injury associated with endotoxemia. TNF alpha exists as a multimer of two, three, or five noncovalently linked units, but shows a single 17 kDa band following SDS PAGE under non reducing conditions. TNF alpha is closely related to the 25 kDa protein Tumour Necrosis Factor beta (lymphotoxin), sharing the same receptors and cellular actions. TNF alpha causes cytolysis or cytostasis of certain transformed cells, being synergistic with interferon gamma in its cytotoxicity. Although it has little effect on many cultured normal human cells, TNF alpha appears to be directly toxic to vascular endothelial cells. Other actions of TNF alpha include stimulating growth of human fibroblasts and other cell lines, activating polymorphonuclear neutrophils and osteoclasts, and induction of interleukin 1, prostaglandin E2 and collagenase production. TNF alpha is currently being evaluated in treatment of certain cancers and AIDS Related Complex.

Function : Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation.

The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells.

Subunit : Homotrimer. Interacts with SPPL2B.

Subcellular Location : Cell membrane; Single-pass type II membrane protein.

Tumor necrosis factor, membrane form: Membrane; Single-pass type II membrane protein.

Tumor necrosis factor, soluble form: Secreted.

C-domain 1: Secreted.

C-domain 2: Secreted.

Post-translational modifications : The soluble form derives from the membrane form by proteolytic processing. The membrane-bound form is further proteolytically processed by SPPL2A or SPPL2B through regulated intramembrane proteolysis producing TNF intracellular domains (ICD1 and ICD2) released in the cytosol and TNF C-domain 1 and C-domain 2 secreted into the extracellular space.

The membrane form, but not the soluble form, is phosphorylated on serine residues. Dephosphorylation of the membrane form occurs by binding to soluble TNFRSF1A/TNFR1.

O-glycosylated; glycans contain galactose, N-acetylgalactosamine and N-acetylneuraminic acid.

DISEASE : Genetic variations in TNF are a cause of susceptibility psoriatic arthritis (PSORAS) [MIM:607507]. PSORAS is an inflammatory, seronegative arthritis associated with psoriasis. It is a heterogeneous disorder ranging from a mild, non-destructive disease to a severe, progressive, erosive arthropathy. Five types of psoriatic arthritis have been defined: asymmetrical oligoarthritis characterized by primary involvement of the small joints of the fingers or toes; asymmetrical arthritis which involves the joints of the extremities; symmetrical polyarthritis characterized by a rheumatoidlike pattern that can involve hands, wrists, ankles, and feet; arthritis mutilans, which is a rare but deforming and destructive condition; arthritis of the sacroiliac joints and spine (psoriatic spondylitis).

Similarity : Belongs to the tumor necrosis factor family.

Database links :

UniProtKB/Swiss-Prot: P01375.1

Entrez Gene: 7124 Human

Omim: 191160 Human

SwissProt: P01375 Human

Unigene: 241570 Human

全、新、優(yōu)、品、好四大特點：

-α抗體說明書 全：公司提供上萬種產品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產品在我司都能找到。

新：產品更新速度較快，基本上每周都有新產品出現(xiàn)。

優(yōu)：產品質量好，投訴比較少。

好：我公司具有優(yōu)質的技術團隊，產品一旦售出，實驗過程中遇到困難可提供在線技術咨詢。使您使用產品時沒有任何的后顧之憂。

正在熱銷的相關產品：

Anti-TIGAR humen/FITC 熒光素標記兔抗人TIGAR蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml

B7-H1/PDL1/CD274(programmed death ligand 1) 程序性死亡配體1(多肽)Multi-class antibodies規(guī)格： 0.5mg

生長抑素受體5抗體 Anti-SSTR5 0.2ml

S100P 英文名稱： S100鈣結合蛋白P抗體 0.1ml

ET-1 英文名稱： 內皮素-1抗體 0.1ml

Rhesus antibody Rh Phospho-MAP2(Ser136) 磷酸化微管相關蛋白2抗體 規(guī)格 0.1ml

B7-H1/PDL1/CD274(programmed death ligand 1) 程序性死亡配體1(多肽)Multi-class antibodies規(guī)格： 0.5mg

GFP (Green Fluorecent protein) 綠色熒光蛋白Multi-class antibodies規(guī)格： 0.5mg

HSPB1 HSP27 / HSPB1 兔單抗 (PE) Human

Rhesus antibody Rh phospho-DAAM1 (Thr361) 磷酸化形態(tài)發(fā)生紊亂關聯(lián)激活因子1抗體 規(guī)格 0.1ml

預染蛋白Marker分子量標準(5.7-170.8kDa) 10次 Invitrogen分裝

ZNRF3 英文名稱： 鋅指蛋白3/環(huán)指蛋白3抗體 0.2ml

DAB2 英文名稱： 信號轉導功能磷蛋白DAB2抗體 0.1ml

HSPB1 HSP27 / HSPB1 兔單抗 (PE) Human

OAT4L又稱URAT1 (Urate Transporter 1) 尿酸鹽重吸收轉運子1 (抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-CD328/Siglec-7 唾液酸結合性免疫球蛋白樣凝集素7抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh ORAV1 高表達的蛋白1抗體 規(guī)格 0.2ml

CIB2 Kit Human 人 CIB2 ELISA配對抗體 ELISA

TRIP 英文名稱： 壞死因子受體相互作用蛋白抗體 0.1ml

CaIPLA2 英文名稱： 胞漿鈣獨立磷脂酶A2抗體 0.1ml

Anti-CD328/Siglec-7 唾液酸結合性免疫球蛋白樣凝集素7抗體Multi-class antibodies規(guī)格： 0.2ml

NAMPT Protein Human 重組人 PBEF / Visfatin / NAMPT 蛋白 (His & GST 標簽)

M17 神經母細胞瘤

CA10 Others Mouse 小鼠 Ca10 / Car10 人細胞裂解液 (陽性對照)

ZR-75-1人癌細胞 Human breast cancer cell line ZR-75-1 RPMI-1640(GIBCO)+10%FBS

BALB/C小鼠肝上皮細胞;BNL 1ME A.7R.1

人胚胎眼鞏膜成纖維細胞;HFSF 人肺大動脈內皮細胞完全培養(yǎng)基 100mL

CL-0297Y3-Ag 1.2.3(大鼠細胞)5×106cells/瓶×2

CLEC4A3 Others Rat 大鼠 CLEC4A3 人細胞裂解液 (陽性對照)

人少突膠質前體細胞(懸浮生長)總RNAHOPC-os NA

MDA-MB-436細胞，人癌細胞 雜交瘤細胞支原體陽性,B6YH4細胞 神經少突起前質膠質細胞Many types of cells包裝：5 × 105次方(1ml)

SF-295(人XG惡性細胞) 5×106cells/瓶×2

HAoEC Pellet 人主動脈內皮細胞團塊 > 1 mio.cells 尿道上皮細胞生長添加物UCGS

-α抗體說明書 NAMPT Protein Human 重組人 PBEF / Visfatin / NAMPT 蛋白 (His & GST 標簽)

M17 神經母細胞瘤

CA10 Others Mouse 小鼠 Ca10 / Car10 人細胞裂解液 (陽性對照)

ZR-75-1人癌細胞 Human breast cancer cell line ZR-75-1 RPMI-1640(GIBCO)+10%FBS

BALB/C小鼠肝上皮細胞;BNL 1ME A.7R.1

人胚胎眼鞏膜成纖維細胞;HFSF 人肺大動脈內皮細胞完全培養(yǎng)基 100mL